Article
Resistance to apoptosis is increased during metastatic dissemination of colon cancer.
Clinical & experimental metastasis - 1 Jan 2002
Oliver L, Cordel S, Barbieux I, LeCabellec M T, Meflah K, Grégoire M, Vallette F M
Abstract excerpt
Apoptosis dysfunction in metastases has been suggested to participate in their poor response to conventional anticancer treatments. To address this question, we have analyzed the sensitivity to cell death induced by non-steroid anti-inflammatory drug, Sulindac, the most common drug used in colon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
